论文部分内容阅读
In recent years, biomacromoleclar are of increasing inerest to the pharmaceutical industry because many diseases would greatly benefit from the use of biomacromoleclar pharmaceuticals.cholera toxin subunit B(CTB), induces a number of signaling molecules related to cellular activation and cytokine production.